the price for 273 will be negotiated in all countries. but Missling will have leverage in all countries for the reason I described...the cost savings from an effective alz treatment.
"someone will make Missling an offer he can't refuse knowing he might have the drug but no way of selling it" that of course is silly, you contract for manufacturing and distribution, either with a BP partner like Pfizer, or a contract manufacturing and distribution arrangement that is even less like a partner and more like a subcontractor...
Who wouldnt want to partner with 273 sales in the potential tens of billions?
News 
Market Data 
Discover 
